Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
53
PRLB Quote, Financials, Valuation and Earnings
Last price:
$50.69
Seasonality move
:
0.41%
Day range:
$50.50 - $51.46
52-week range:
$29.59 - $55.90
Dividend yield:
0%
P/E ratio:
82.56x
P/S ratio:
2.37x
P/B ratio:
1.80x
Volume:
89.8K
Avg. volume:
147.2K
1-year change:
29.42%
Market cap:
$1.2B
Revenue:
$500.9M
EPS (TTM):
$0.61
Analysts' Opinion
-
Consensus RatingProto Labs, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $53.33, Proto Labs, Inc. has an estimated upside of 12.01% from its current price of $50.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $51.00 representing 100% downside risk from its current price of $50.59.
Fair Value
-
According to the consensus of 5 analysts, Proto Labs, Inc. has 12.01% upside to fair value with a price target of $53.33 per share.
PRLB vs. S&P 500
-
Over the past 5 trading days, Proto Labs, Inc. has underperformed the S&P 500 by -3.68% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Proto Labs, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Proto Labs, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Proto Labs, Inc. reported revenues of $135.4M.
Earnings Growth
-
Proto Labs, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Proto Labs, Inc. reported earnings per share of $0.30.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
2.37x
EV / EBIT:
47.94x
EV / Revenue:
2.09x
PEG ratio (5yr expected):
--
EV / Free cash flow:
15.96x
Price / Operating cash flow:
18.15x
Enterprise value / EBITDA:
18.94x
Gross Profit (TTM):
$228.7M
Return On Assets:
1.97%
Net Income Margin (TTM):
2.86%
Return On Equity:
2.22%
Return On Invested Capital:
2.21%
Operating Margin:
6.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $494.4M | $504.2M | $518.4M | $125.6M | $135.4M | |
| Gross Profit | $214.8M | $227.1M | $228.7M | $57.2M | $61.3M | |
| Operating Income | $21.4M | $29.8M | $22.6M | $8.6M | $8.9M | |
| EBITDA | $59M | $66.1M | $57.1M | $17.5M | $17.3M | |
| Diluted EPS | -$3.85 | $0.94 | $0.61 | $0.29 | $0.30 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $172.1M | $192.4M | $204.5M | $193.1M | $225.8M | |
| Total Assets | $930.3M | $906.9M | $784.2M | $753.8M | $756.9M | |
| Current Liabilities | $56.1M | $60.7M | $74.6M | $53.8M | $69.7M | |
| Total Liabilities | $105.7M | $96.1M | $99.3M | $73.8M | $92.1M | |
| Total Equity | $824.6M | $810.8M | $684.9M | $680M | $664.7M | |
| Total Debt | $4.8M | $4M | $18.8M | $2.7M | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $66.6M | $77.8M | $75.3M | $24.8M | $29.1M | |
| Cash From Investing | $10.1M | -$25.1M | -$10.7M | -$14.3M | -$4.3M | |
| Cash From Financing | -$53.9M | -$49.1M | -$48.4M | -$19.1M | -$10.7M | |
| Free Cash Flow | $51.4M | $32.2M | $67.7M | $5.1M | $25M | |
PRLB
Sector
Market Cap
$1.2B
$486.6M
Price % of 52-Week High
90.5%
79.79%
Dividend Yield
0%
0%
Shareholder Yield
3.67%
1.52%
1-Year Price Total Return
29.42%
--
Beta (5-Year)
1.158
0.534
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$52.33
200-day SMA
Buy
Level
$44.40
Bollinger Bands (100)
Buy
Level
48.57 - 52.53
Chaikin Money Flow
Sell
Level
-614.8K
20-day SMA
Sell
Level
$52.20
Relative Strength Index (RSI14)
Sell
Level
43.00
ADX Line
Sell
Level
21.77
Williams %R
Buy
Level
-97.2892
50-day SMA
Sell
Level
$51.17
MACD (12, 26)
Buy
Level
14.26
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.1946)
Buy
CA Score
(Annual)
Level (1.6451)
Buy
Beneish M-Score
(Annual)
Level (-2.9629)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-2.8691)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Proto Labs, Inc. engages in the manufacture of custom prototypes and production parts. It offers 3D printing, CNC machining, and injection molding services. It operates through the following geographical segments: United States, Europe, and Corporate and Japan. The company was founded by Lawrence J. Lukis and Gregg Bloom on May 5, 1999 and is headquartered in Maple Plain, MN.
Stock Forecast FAQ
In the current month, PRLB has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The PRLB average analyst price target in the past 3 months is $53.33.
-
Where Will Proto Labs, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Proto Labs, Inc. share price will rise to $53.33 per share over the next 12 months.
-
What Do Analysts Say About Proto Labs, Inc.?
Analysts are divided on their view about Proto Labs, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Proto Labs, Inc. is a Sell and believe this share price will drop from its current level to $51.00.
-
What Is Proto Labs, Inc.'s Price Target?
The price target for Proto Labs, Inc. over the next 1-year time period is forecast to be $53.33 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is PRLB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Proto Labs, Inc. is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PRLB?
You can purchase shares of Proto Labs, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Proto Labs, Inc. shares.
-
What Is The Proto Labs, Inc. Share Price Today?
Proto Labs, Inc. was last trading at $50.69 per share. This represents the most recent stock quote for Proto Labs, Inc.. Yesterday, Proto Labs, Inc. closed at $50.59 per share.
-
How To Buy Proto Labs, Inc. Stock Online?
In order to purchase Proto Labs, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PRLB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRLB
Sector
P/E ratio
82.56x
19.19x
PEG ratio
--
0.18x
P/B ratio
1.80x
1.69x
Price / LTM sales
2.37x
0.85x
Growth Metrics
PRLB
Sector
Revenue growth
7.76%
5.01%
Earnings growth
3.83%
5.65%
Revenue (5-year growth)
1.77%
4.27%
Earnings forecast
$0.34
$0.35
Profitability
PRLB
Sector
Profitability FY 2024
$223.2M
$252.3M
Return on invested capital
2.21%
4.72%
Return on assets
1.97%
3.09%
Return on equity
2.22%
8.11%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Feb
6
Estimated Next Earnings Date
Jan
30
Balance Sheet
PRLB
Sector
Total cash
$119.2M
$138.8M
Short term investments
$14M
$32.3M
Total assets
$768.7M
$1.4B
Long term debt
$1.6M
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
